• Cancer treatment
• Clinical trial
• Immunotherapy
• Immunotherapy research
• Memorial Sloan Kettering Cancer Center
• Neoantigens
• Pancreatic cancer
• PDAC
• Personalized vaccine
• T cells

Breakthrough Personalized Vaccine Shows Promise in Fighting Deadly Pancreatic Cancer

• 

  IMP20233 / 2 years
• 0
• 3 min read

Pancreatic ductal adenocarcinoma (PDAC), the most common and deadliest form of pancreatic cancer, continues to pose a significant challenge in terms of effective treatment. Despite advancements in therapies, the survival rate for individuals diagnosed with PDAC remains alarmingly low, with only about 12% surviving beyond five years of treatment. In a groundbreaking development, a research […]